BCM
IAS

Bayesian Capital Management’s Integral Ad Science IAS Stock Holding History

Bayesian Capital Management’s Portfolio IAS Stock Details IAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,100
Closed -$468K – 699
2025
Q1 		$468K Buy
+58,100
New +$580K 0.08% 304
2024
Q3 		– Sell
-106,800
Closed -$1.04M – 844
2024
Q2 		$1.04M Buy
+106,800
New +$1.02M 0.12% 224
2024
Q1 		– Sell
-17,300
Closed -$249K – 928
2023
Q4 		$249K Buy
17,300
+5,700
+49% +$76.3K 0.03% 552
2023
Q3 		$138K Buy
+11,600
New +$179K 0.02% 583
2023
Q2 		– Sell
-15,900
Closed -$227K – 920
2023
Q1 		$227K Buy
+15,900
New +$179K 0.03% 581

Other funds holding IAS

VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bayesian Capital Management's IAS Position: Q2 2025 in Review

Bayesian Capital Management sold out of Integral Ad Science (IAS) in Q2 2025, closing a stake of 58,100 shares — an estimated $468K sold.

Bayesian Capital Management first reported a position in IAS in Q1 2023 and held it in 5 quarters. The position peaked at $1.04M in Q2 2024. 170 funds tracked by Wall St. Rank hold IAS as of Q2 2025.

  • Bayesian Capital Management reported no remaining Integral Ad Science position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 58,100 Integral Ad Science shares in Q2 2025, an estimated $468K.
  • Bayesian Capital Management first reported a position in Integral Ad Science in Q1 2023 and held it in 5 quarters.
  • Bayesian Capital Management's Integral Ad Science position peaked at $1.04M in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Integral Ad Science as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.